These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 30502114)

  • 1. Clinical aspects of radiolabeled aptamers in diagnostic nuclear medicine: A new class of targeted radiopharmaceuticals.
    Farzin L; Shamsipur M; Moassesi ME; Sheibani S
    Bioorg Med Chem; 2019 Jun; 27(12):2282-2291. PubMed ID: 30502114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aptamers as radiopharmaceuticals for nuclear imaging and therapy.
    Gijs M; Aerts A; Impens N; Baatout S; Luxen A
    Nucl Med Biol; 2016 Apr; 43(4):253-71. PubMed ID: 26746572
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Kang L; Rosenkrans ZT; Cai W
    Methods Mol Biol; 2019; 1974():223-231. PubMed ID: 31099007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor targeting by an aptamer.
    Hicke BJ; Stephens AW; Gould T; Chang YF; Lynott CK; Heil J; Borkowski S; Hilger CS; Cook G; Warren S; Schmidt PG
    J Nucl Med; 2006 Apr; 47(4):668-78. PubMed ID: 16595502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring Aqueous Coordination Chemistry of Highly Lewis Acidic Metals with Emerging Isotopes for Nuclear Medicine.
    Whetter JN; Śmiłowicz D; Boros E
    Acc Chem Res; 2024 Mar; 57(6):933-944. PubMed ID: 38501206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (1→3)-β-D-glucan aptamers labeled with technetium-99m: Biodistribution and imaging in experimental models of bacterial and fungal infection.
    de Sousa Lacerda CM; Ferreira IM; Dos Santos SR; de Barros AL; Fernandes SO; Cardoso VN; de Andrade AS
    Nucl Med Biol; 2017 Mar; 46():19-24. PubMed ID: 27951452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of mono- and multimeric targeted radiopharmaceuticals based on novel cyclen ligands coupled to anti-MUC1 aptamers for the diagnostic imaging and targeted radiotherapy of cancer.
    Borbas KE; Ferreira CS; Perkins A; Bruce JI; Missailidis S
    Bioconjug Chem; 2007; 18(4):1205-12. PubMed ID: 17583928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 18F-Labeled Single-Stranded DNA Aptamer for PET Imaging of Protein Tyrosine Kinase-7 Expression.
    Jacobson O; Weiss ID; Wang L; Wang Z; Yang X; Dewhurst A; Ma Y; Zhu G; Niu G; Kiesewetter DO; Vasdev N; Liang SH; Chen X
    J Nucl Med; 2015 Nov; 56(11):1780-1785. PubMed ID: 26315836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Staphylococcus aureus infection by aptamers directly radiolabeled with technetium-99m.
    dos Santos SR; Rodrigues Corrêa C; Branco de Barros AL; Serakides R; Fernandes SO; Cardoso VN; de Andrade AS
    Nucl Med Biol; 2015 Mar; 42(3):292-8. PubMed ID: 25533762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioconjugates of Chelators with Peptides and Proteins in Nuclear Medicine: Historical Importance, Current Innovations, and Future Challenges.
    Jackson JA; Hungnes IN; Ma MT; Rivas C
    Bioconjug Chem; 2020 Mar; 31(3):483-491. PubMed ID: 31990543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aptamers as a novel tool for diagnostics and therapy.
    Kadioglu O; Malczyk AH; Greten HJ; Efferth T
    Invest New Drugs; 2015 Apr; 33(2):513-20. PubMed ID: 25637166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-specific aptamers and their conjugation with nanomaterials for targeted drug delivery.
    Liao J; Liu B; Liu J; Zhang J; Chen K; Liu H
    Expert Opin Drug Deliv; 2015 Mar; 12(3):493-506. PubMed ID: 25430795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SELEX methods on the road to protein targeting with nucleic acid aptamers.
    Bayat P; Nosrati R; Alibolandi M; Rafatpanah H; Abnous K; Khedri M; Ramezani M
    Biochimie; 2018 Nov; 154():132-155. PubMed ID: 30193856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiometal complexes in molecular imaging and therapy.
    Rey AM
    Curr Med Chem; 2010; 17(31):3673-83. PubMed ID: 20846111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Derivatizations of Sgc8-c aptamer to prepare metallic radiopharmaceuticals as imaging diagnostic agents: Syntheses, isolations, and physicochemical characterizations.
    Sicco E; Báez J; Margenat J; García F; Ibarra M; Cabral P; Moreno M; Cerecetto H; Calzada V
    Chem Biol Drug Des; 2018 Mar; 91(3):747-755. PubMed ID: 29080264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards Clinical Development of Scandium Radioisotope Complexes for Use in Nuclear Medicine: Encouraging Prospects with the Chelator 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic Acid (DOTA) and Its Analogues.
    Ioannidis I; Lefkaritis G; Georgiades SN; Pashalidis I; Kontoghiorghes GJ
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aptamers directly radiolabeled with technetium-99m as a potential agent capable of identifying carcinoembryonic antigen (CEA) in tumor cells T84.
    Correa CR; de Barros AL; Ferreira Cde A; de Goes AM; Cardoso VN; de Andrade AS
    Bioorg Med Chem Lett; 2014 Apr; 24(8):1998-2001. PubMed ID: 24675379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiolabelled aptamers for tumour imaging and therapy.
    Perkins AC; Missailidis S
    Q J Nucl Med Mol Imaging; 2007 Dec; 51(4):292-6. PubMed ID: 17464274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aptamer-based technology for radionuclide targeted imaging and therapy: a promising weapon against cancer.
    Filippi L; Bagni O; Nervi C
    Expert Rev Med Devices; 2020 Aug; 17(8):751-758. PubMed ID: 32669004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.